NCT07334431 2026-01-12
Fruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With HER2-positive Advanced Gastric Cancer
Henan Cancer Hospital
Phase 1/2 Recruiting
Clinical Trials
6 trialsNCT06227325 2024-01-26
Disitamab Vedotin Combined With Sintilimab and XELOX Perioperative Treatment for Resectable Gastric Caner With HER2 Overexpression
Henan Cancer Hospital
Phase 2 Unknown
NCT03957733 2022-04-06
Phase II/III Study to Assess the Efficacy of Neoadjuvant Consolidation Chemotherapy in Rectal Cancer Patients.
King Abdullah Medical City
Phase 2/3 Unknown
NCT04747951 2021-02-15
Total Neoadjuvant Therapy in Rectal Cancer Treatment
State Scientific Centre of Coloproctology, Russian Federation
Phase 4 Unknown
NCT03599778 2018-07-26
XELOX Combined With Apatinib as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma
Anhui Provincial Hospital
Phase 1/2 Unknown
NCT01952951 2017-09-13
PREPARE
National Cancer Center, Korea
Phase 2 Unknown